The U.S. health regulator asked drugmakers on Tuesday to remove label warnings about a potential risk of suicidal thoughts ...
The US Food and Drug Administration found no increased risk of suicidal behavior or ideation linked to popular weight-loss ...
The U.S. health regulator on Tuesday asked drugmakers to remove label warnings about a potential risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk’s Wegovy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback